Virtu Financial’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,485
Closed -$14K 1804
2024
Q2
$14K Buy
1,485
+638
+75% +$7.08K ﹤0.01% 1085
2024
Q1
$11K Buy
+847
New +$15.1K ﹤0.01% 1245
2023
Q4
Sell
-795
Closed -$10K 1928
2023
Q3
$10K Buy
795
+366
+85% +$9.57K ﹤0.01% 1110
2023
Q2
$13K Buy
+429
New +$24.7K ﹤0.01% 1327
2022
Q4
Sell
-62
Closed -$31K 2056
2022
Q3
$31K Buy
62
+19
+44% +$16.6K ﹤0.01% 1309
2022
Q2
$37K Buy
43
+16
+59% +$22K ﹤0.01% 1200
2022
Q1
$68K Buy
+27
New +$64K 0.01% 1056
2021
Q4
Sell
-19
Closed -$88K 2097
2021
Q3
$88K Buy
+19
New +$129K 0.01% 1178
2021
Q1
Sell
-30
Closed -$244K 1946
2020
Q4
$244K Buy
30
+12
+67% +$108K 0.03% 752
2020
Q3
$181K Buy
+18
New +$148K 0.03% 606
2019
Q4
$62K Buy
+10
New +$63.9K 0.01% 1170
2019
Q3
Sell
-11
Closed -$72K 1768
2019
Q2
$72K Buy
+11
New +$84.7K ﹤0.01% 1184
2018
Q1
Sell
-61
Closed -$312K 2477
2017
Q4
$312K Buy
+61
New +$411K 0.02% 1231

Other funds holding RDHL

Virtu Financial's RDHL Position: Q3 2024 in Review

Virtu Financial sold out of Redhill Biopharma (RDHL) in Q3 2024, closing a stake of 1,485 shares — an estimated $14K sold.

Virtu Financial first reported a position in RDHL in Q4 2017 and held it in 13 quarters. The position peaked at $312K in Q4 2017. 11 funds tracked by Wall St. Rank hold RDHL as of Q3 2024.

  • Virtu Financial reported no remaining Redhill Biopharma position as of Q3 2024 after selling out during the quarter.
  • Virtu Financial sold 1,485 Redhill Biopharma shares in Q3 2024, an estimated $14K.
  • Virtu Financial first reported a position in Redhill Biopharma in Q4 2017 and held it in 13 quarters.
  • Virtu Financial's Redhill Biopharma position peaked at $312K in Q4 2017.
  • 11 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.